• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆血管内皮生长因子及其可溶性受体sFlt-1是动脉粥样硬化的危险因素吗?来自SAPHIR研究的横断面数据。

Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study.

作者信息

Sandhofer A, Tatarczyk T, Kirchmair R, Iglseder B, Paulweber B, Patsch J R, Schratzberger P

机构信息

Department of Internal Medicine I, Innsbruck Medical University, Anichstrasse 35, Innsbruck, Austria.

出版信息

Atherosclerosis. 2009 Sep;206(1):265-9. doi: 10.1016/j.atherosclerosis.2009.01.031. Epub 2009 Feb 3.

DOI:10.1016/j.atherosclerosis.2009.01.031
PMID:19237157
Abstract

AIMS

Vascular endothelial growth factor (VEGF) is a potent hypoxia-regulated angiogenic factor. Its soluble receptor soluble (s)Flt-1 binds VEGF with high affinity inhibiting the angiogenic function of VEGF. The role of circulating VEGF in atherosclerosis is unclear.

METHODS AND RESULTS

In 909 healthy subjects (511 male, 398 female) from the Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk (SAPHIR) we determined fasting plasma VEGF and sFlt-1 concentration, cardiovascular risk factors and carotid atherosclerosis. VEGF levels were lower and sFlt-1 levels higher in men than in women. VEGF and sFlt-1 showed a positive correlation. In the entire population VEGF correlated positively with age, BMI, insulin resistance, white blood cell and platelet count, C-reactive protein (CRP) and carotid intima media thickness (IMT). After adjustment for age, VEGF showed a weak positive correlation with BMI, liver enzymes, CRP and platelet count in males. In females VEGF correlated negatively with LDL-cholesterol and positively with insulin resistance and platelet count. After adjustment for age, no significant correlation with carotid atherosclerosis could be detected.

CONCLUSION

Plasma VEGF and sFlt-1 are only weakly correlated with cardiovascular risk factors, suggesting that circulating VEGF levels do have only a minor impact on the development of atherosclerosis.

摘要

目的

血管内皮生长因子(VEGF)是一种强效的缺氧调节血管生成因子。其可溶性受体可溶性(s)Flt-1与VEGF具有高亲和力结合,抑制VEGF的血管生成功能。循环VEGF在动脉粥样硬化中的作用尚不清楚。

方法和结果

在来自萨尔茨堡高危个体动脉粥样硬化预防项目(SAPHIR)的909名健康受试者(511名男性,398名女性)中,我们测定了空腹血浆VEGF和sFlt-1浓度、心血管危险因素和颈动脉粥样硬化情况。男性的VEGF水平低于女性,sFlt-1水平高于女性。VEGF和sFlt-1呈正相关。在整个人群中,VEGF与年龄、体重指数、胰岛素抵抗、白细胞和血小板计数、C反应蛋白(CRP)以及颈动脉内膜中层厚度(IMT)呈正相关。在调整年龄后,男性中VEGF与体重指数、肝酶、CRP和血小板计数呈弱正相关。在女性中,VEGF与低密度脂蛋白胆固醇呈负相关,与胰岛素抵抗和血小板计数呈正相关。调整年龄后,未检测到与颈动脉粥样硬化有显著相关性。

结论

血浆VEGF和sFlt-1与心血管危险因素仅呈弱相关,提示循环VEGF水平对动脉粥样硬化的发展影响较小。

相似文献

1
Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study.血浆血管内皮生长因子及其可溶性受体sFlt-1是动脉粥样硬化的危险因素吗?来自SAPHIR研究的横断面数据。
Atherosclerosis. 2009 Sep;206(1):265-9. doi: 10.1016/j.atherosclerosis.2009.01.031. Epub 2009 Feb 3.
2
Soluble fms-like tyrosine kinase-1 and the progression of carotid intima-media thickness – 24-month follow-up study –.可溶性 fms 样酪氨酸激酶-1 与颈动脉内膜中层厚度的进展——24 个月随访研究——。
Circ J. 2010 Oct;74(10):2211-5. doi: 10.1253/circj.cj-10-0432. Epub 2010 Aug 3.
3
Exercise increases soluble vascular endothelial growth factor receptor-1 (sFlt-1) in circulation of healthy volunteers.运动可增加健康志愿者循环中的可溶性血管内皮生长因子受体-1(sFlt-1)。
Med Sci Monit. 2006 Feb;12(2):CR45-50. Epub 2006 Jan 26.
4
Plasma leptin is independently associated with the intima-media thickness of the common carotid artery.血浆瘦素与颈总动脉内膜中层厚度独立相关。
Int J Obes Relat Metab Disord. 2001 Jun;25(6):805-10. doi: 10.1038/sj.ijo.0801623.
5
Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study).系统性红斑狼疮加速动脉粥样硬化中的传统和非传统危险因素:血管内皮生长因子的作用(VEGATS研究)
Autoimmun Rev. 2009 Feb;8(4):309-15. doi: 10.1016/j.autrev.2008.10.002. Epub 2008 Oct 29.
6
Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays.液体样本中游离和复合可溶性血管内皮生长因子受体Flt-1的检测:两种新型免疫测定法的开发与应用
Clin Sci (Lond). 2001 May;100(5):567-75.
7
Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy.糖尿病肾病中的血管内皮生长因子(VEGF)和可溶性VEGF受体FLT-1
Kidney Int. 2005 Jan;67(1):167-77. doi: 10.1111/j.1523-1755.2005.00067.x.
8
Variation in the vascular endothelial growth factor gene, carotid intima-media thickness and the risk of acute myocardial infarction.血管内皮生长因子基因变异、颈动脉内膜中层厚度与急性心肌梗死风险
Scand J Clin Lab Invest. 2009;69(3):335-43. doi: 10.1080/00365510802607520.
9
Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers.子痫前期母亲早产新生儿中可溶性fms样酪氨酸激酶1水平过高及血小板计数偏低
Pediatrics. 2005 Aug;116(2):468-72. doi: 10.1542/peds.2004-2240.
10
Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.阿托伐他汀可增加急性心肌梗死患者血浆可溶性Fms样酪氨酸激酶-1水平,降低血管内皮生长因子和胎盘生长因子水平,同时改善心室功能。
J Am Coll Cardiol. 2006 Jul 4;48(1):43-50. doi: 10.1016/j.jacc.2006.03.035. Epub 2006 Jun 9.

引用本文的文献

1
The Association between Single Nucleotide Polymorphisms, including miR-499a Genetic Variants, and Dyslipidemia in Subjects Treated with Pharmacological or Phytochemical Lipid-Lowering Agents.接受药物或植物化学降脂剂治疗的受试者中单核苷酸多态性(包括 miR-499a 遗传变异)与血脂异常的关联。
Int J Mol Sci. 2022 May 17;23(10):5617. doi: 10.3390/ijms23105617.
2
VEGF-A in Cardiomyocytes and Heart Diseases.血管内皮生长因子 A 在心肌细胞和心脏疾病中的作用。
Int J Mol Sci. 2020 Jul 26;21(15):5294. doi: 10.3390/ijms21155294.
3
Serum Vascular Endothelial Growth Factor in Egyptian Obese Women with Insulin Resistance.
埃及肥胖且有胰岛素抵抗女性的血清血管内皮生长因子
Open Access Maced J Med Sci. 2019 Apr 29;7(8):1330-1334. doi: 10.3889/oamjms.2019.156. eCollection 2019 Apr 30.
4
Association between the expression of vascular endothelial growth factors and metabolic syndrome or its components: a systematic review and meta-analysis.血管内皮生长因子表达与代谢综合征及其组分之间的关联:一项系统评价和Meta分析
Diabetol Metab Syndr. 2018 Aug 3;10:62. doi: 10.1186/s13098-018-0363-0. eCollection 2018.
5
Overweight and obesity versus concentrations of VEGF-A, sVEGFR-1, and sVEGFR-2 in plasma of patients with lower limb chronic ischemia.下肢慢性缺血患者超重和肥胖与血浆中血管内皮生长因子-A、可溶性血管内皮生长因子受体-1和可溶性血管内皮生长因子受体-2浓度的关系
J Zhejiang Univ Sci B. 2016;17(11):842-849. doi: 10.1631/jzus.B1600009.
6
Angiogenesis related genes NOS3, CD14, MMP3 and IL4R are associated to VEGF gene expression and circulating levels in healthy adults.血管生成相关基因NOS3、CD14、MMP3和IL4R与健康成年人的VEGF基因表达及循环水平相关。
BMC Med Genet. 2015 Oct 5;16:90. doi: 10.1186/s12881-015-0234-6.
7
Association between the polymorphisms of the vascular endothelial growth factor gene and metabolic syndrome.血管内皮生长因子基因多态性与代谢综合征之间的关联
Biomed Rep. 2015 May;3(3):319-326. doi: 10.3892/br.2015.423. Epub 2015 Feb 4.
8
Association of vascular endothelial factors with cardiovascular outcome and mortality in chronic kidney disease patients: a 4-year cohort study.血管内皮因子与慢性肾脏病患者心血管结局及死亡率的关联:一项为期4年的队列研究。
Atherosclerosis. 2014 Oct;236(2):360-5. doi: 10.1016/j.atherosclerosis.2014.07.026. Epub 2014 Aug 12.
9
The association of serum vascular endothelial growth factor and ferritin in diabetic microvascular disease.血清血管内皮生长因子与铁蛋白在糖尿病微血管病变中的关联
Diabetes Technol Ther. 2014 Apr;16(4):224-34. doi: 10.1089/dia.2013.0181. Epub 2013 Nov 26.
10
Serum brain-derived neurotrophic factor and vascular endothelial growth factor levels are associated with risk of stroke and vascular brain injury: Framingham Study.血清脑源性神经营养因子和血管内皮生长因子水平与中风和血管性脑损伤的风险相关:弗雷明汉研究。
Stroke. 2013 Oct;44(10):2768-75. doi: 10.1161/STROKEAHA.113.001447. Epub 2013 Aug 8.